DoctorRachel Atkinson
Lecturer in Dementia Studies
Wicking Dementia Research Education Centre
Orcid identifier0000-0002-9846-7738 (opens in a new tab)
- Lecturer in Dementia StudiesWicking Dementia Research Education Centre
- +61 3 6226 4278 (Work)
- Wicking Dementia Research Education Centre, Wicking Dementia Research and Education Centre, 417-22, Level 4 Medical Science 1, Hobart CBD Campuses, TAS
RESEARCH SUMMARy
Rachel’s research aligns to the University’s research theme of Better Health and with the NHMRA priority areas of Dementia and Ageing Well. As a member of the Wicking Centre, her research is targeted towards better understanding of the cellular and molecular mechanisms which underpin dementia. Rachel’s particular interests include understanding the underlying causes of frontotemporal dementia and amyotrophic lateral sclerosis.
Frontotemporal dementia is the second most common cause of younger onset dementia, and amyotrophic lateral sclerosis is the most common form of motor neuron disease. A number of proteins have been implicated in playing roles in these diseases. Rachel’s research proposes that these proteins play a role in maintaining the long nerve processes of neurons, and, in disease this results in disconnection of neurons within the nervous system. In order to study these proteins, Rachel uses viruses, like those that infect humans, to inject cells in the brain and in the dish and cause them to express mutant forms of proteins involved in frontotemporal dementia and amyotrophic lateral sclerosis. These techniques allow the mechanisms by which these proteins cause nerve cells to dysfunction to be further deciphered.
Expertise:
Tissue Culture (primary mouse and stem cell)
Molecular Biology (cloning) and construct design
Viral techniques
Behavioural studies in mice
Advanced microscopy
Frontotemporal dementia is the second most common cause of younger onset dementia, and amyotrophic lateral sclerosis is the most common form of motor neuron disease. A number of proteins have been implicated in playing roles in these diseases. Rachel’s research proposes that these proteins play a role in maintaining the long nerve processes of neurons, and, in disease this results in disconnection of neurons within the nervous system. In order to study these proteins, Rachel uses viruses, like those that infect humans, to inject cells in the brain and in the dish and cause them to express mutant forms of proteins involved in frontotemporal dementia and amyotrophic lateral sclerosis. These techniques allow the mechanisms by which these proteins cause nerve cells to dysfunction to be further deciphered.
Expertise:
Tissue Culture (primary mouse and stem cell)
Molecular Biology (cloning) and construct design
Viral techniques
Behavioural studies in mice
Advanced microscopy
FUNDED PROJECTS
- GRANTOptogenetic models of TDP-43 proteinopathy in MND1 Jan 2026 - 31 Dec 2026People funded by this grant:
- Reading A,
- Lin J,
- Phipps A,
- Atkinson R,
- Cook T
- GRANTProtecting against axon degeneration in MND1 Jan 2025 - 31 Mar 2026People funded by this grant:
- Phipps A,
- King A,
- Atkinson R,
- Collins J,
- Thorne B
- GRANTUnderstanding Axon degeneration in MND1 Jan 2025 - 31 Dec 2025People funded by this grant:
- Phipps A,
- King A,
- Atkinson R,
- Clark R,
- Wilson R
- GRANTThe Cellular Consequences of Oligogenic/Polygenic Inheritance in ALS1 Oct 2024 - 30 Sep 2027People funded by this grant:
- Cook T,
- Thorne B,
- King A,
- Perry S,
- Atkinson R
- GRANTFreezing MND in its tracks18 Mar 2024 - 18 Oct 2027People funded by this grant:
- Atkinson R
- GRANTBrian Marks Research Grant: A human stem-cell derived model of the neuro-muscular junction to investigate axonal alterations caused by C9ORF72 pathogenic repeat expansion1 Jan 2023 - 21 Apr 2026People funded by this grant:
- Atkinson R
- GRANTSiganto Foundation HDR student Career Development Scholarship in dementia research1 Jan 2023 - 1 Jul 2025People funded by this grant:
- Phipps A,
- Dixit D,
- King A,
- Atkinson R
- GRANTEpidemiology in a dish: using human iPSC to discover common and genotype-specific molecular signatures of the multi-step hypothesis of ALS1 Sep 2022 - 31 Mar 2026People funded by this grant:
- Cook T,
- Perry S,
- King A,
- Atkinson R,
- Phipps A
- GRANTTo die or not to die: What is the mechanism of axon degeneration in ALS?1 Jan 2022 - 30 Jun 2023People funded by this grant:
- Phipps A,
- Atkinson R,
- Perry S,
- King A,
- Cook T
- GRANTA potential metabolic-targeted therapeutic for Amyotrophic lateral sclerosis (ALS): Leptin15 Sep 2019 - 31 Dec 2023People funded by this grant:
- Fernandez Martos C,
- King A,
- Del Olmo Izquierdo N,
- Sreedharan J,
- Vickers J
- GRANTDo Renshaw cells have a role in amyotrophic lateral sclerosis disease progression1 May 2019 - 31 Dec 2019People funded by this grant:
- Perry S,
- Atkinson R,
- King A
- GRANTProteomic analysis of exosomes from iPS cell-derived neurons with mislocalised TDP-431 Jan 2019 - 1 Jan 2020People funded by this grant:
- Cook T,
- King A,
- Atkinson R,
- Perry S,
- Hewitt A
- GRANTThe role of FTLD proteins in neurite health, function and dysfunction1 Mar 2014 - 1 Mar 2017People funded by this grant:
- King A,
- Atkinson R,
- Vickers J